France stocks lower at close of trade; CAC 40 down 0.24% -Breaking
[ad_1]
© Reuters. France stocks are lower as of close to trade. CAC40 is down by 0.24%Investing.com – France stocks were lower after the close on Friday, as losses in the , and sectors led shares lower.
The index fell 0.2% at the Paris close, and the dollar dropped by 0.2%.
Sanofi SA (PA) was the best performer of the session, rising 2.90% or 2.44 point to trade at 86.53 by the close. Meanwhile, Carrefour Late trade saw SA (PA) gain 2.87%, or 0.43 point to 15.58. Eurofins Scientific SE was up 0.65%, or 0.70 points at 107.94.
Compagnie de Saint Gobain SA, which lost 2.29% (or 1.40 points) to close at 59.81 was the worst performer of the session. Safran The SA (PA) fell 2.02%, or 2.14 points, to finish at 103.82 Worldline SA (PA:) fell 1.76% (0.86 points) to 48.13
Sanofi SA, PA: rose 2.9% to 86.53 and Carrefour SA, PA: was up 2.87%. They settled at 15.58. Biomerieux SA (PA.:) gained 2.38% and closed at 124.90.
They were among the most disappointing. Neoen SA (PA:), which fell 3.19% to $35.18 in late-trade, Ubisoft Entertainment (PA:), which fell 3.05% to settle for 42.28 Derichebourg (PA:), which fell 2.85% to 9.37 by the end.
The Paris Stock Exchange saw falling stocks surpass advancing stock by 342 to 262 while 93 ended the same.
The was unchanged at 0%, to 18.96, an all-time 52 week low.
For February delivery, Gold Futures rose 0.42% to $1784.25 per troy an ounce. Other commodities traded included Crude oil, which rose 0.42 percent to reach $71.36/barrel in January. The February Brent oil contract, however, rose 0.37 percent to trade at $74.79/barrel.
EUR/USD was 0.224% higher at 1.1319; EUR/GBP declined 0.1% to 0.8531.
US Dollar Index Futures were down 0.2% at 96.010.
Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information, including buy/sell signal data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]
